Literature DB >> 17919561

Effect of protein kinase C and Ca(2+) on p42/p44 MAPK, Pyk2, and Src activation in rat conjunctival goblet cells.

Robin R Hodges1, Yoshitaka Horikawa, Jose D Rios, Marie A Shatos, Darlene A Dartt.   

Abstract

Conjunctival goblet cells synthesize and secrete mucins onto the ocular surface to lubricate it and protect it from bacterial infections. Mucin secretion is under neural control, and cholinergic agonists released from parasympathetic nerves are major stimuli of this secretion. The signal transduction pathways these agonists use to stimulate secretion involve activating protein kinase C (PKC) and increasing intracellular [Ca(2+)] to activate the non-receptor kinases Pyk2 and p60Src (Src) to transactivate the EGF receptor. Transactivation of the EGF receptor activates a kinase cascade culminating in the activation of p42/p44 MAPK (MAPK) and ultimately that leads to secretion of high molecular weight glycocongujates (HMWGC), including mucins. To further examine the roles of PKC and Ca(2+) in the activation of MAPK, Pyk2, and Src in mucin secretion, rat conjunctival pieces and cultured goblet cells were incubated with the PKC activator phorbol myristate acid (PMA), the cholinergic agonist carbachol, or the calcium ionophore, ionomycin for varying times. Conjunctival pieces were preincubated with PKC inhibitors 10min prior to addition of carbachol (10(-4)M) for 10min. The amount of phosphorylated (activated) MAPK, Pyk2 and Src was determined by Western blotting techniques using antibodies specific to the phosphorylated forms of each kinase. PMA significantly increased the activation of MAPK, Pyk2, and Src in a time and concentration-dependent manner. PMA-stimulated MAPK activity was completely inhibited by the EGF receptor inhibitor AG1478 (10(-7)M). Carbachol-stimulated MAPK activity was inhibited by three PKC inhibitors, calphostin C, chelethyrine, and staurosporine. Ionomycin (10(-6)M)-stimulated MAPK activity was inhibited 66% by AG1478 (10(-7)M). Ionomycin also significantly increased Pyk2 and Src in time dependent manner. PKC and ionomycin also activated p42/p44 MAPK, Pyk2, and Src in cultured conjunctival goblet cells. We conclude that PKC and intracellular Ca(2+) activate Pyk2 and Src and phosphorylate the EGF receptor leading to stimulation of MAPK in conjunctival goblet cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17919561      PMCID: PMC2277506          DOI: 10.1016/j.exer.2007.08.019

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  31 in total

Review 1.  The epidermal growth factor receptor family.

Authors:  L A Bazley; W J Gullick
Journal:  Endocr Relat Cancer       Date:  2005-07       Impact factor: 5.678

2.  Effects of alpha1D-adrenergic receptors on shedding of biologically active EGF in freshly isolated lacrimal gland epithelial cells.

Authors:  LiLi Chen; Robin R Hodges; Chika Funaki; Driss Zoukhri; Robert J Gaivin; Dianne M Perez; Darlene A Dartt
Journal:  Am J Physiol Cell Physiol       Date:  2006-06-07       Impact factor: 4.249

3.  The role of proline-rich protein tyrosine kinase 2 in differentiation-dependent signaling in human epidermal keratinocytes.

Authors:  Eva M Schindler; Magdalena Baumgartner; Erin M Gribben; Li Li; Tatiana Efimova
Journal:  J Invest Dermatol       Date:  2007-01-04       Impact factor: 8.551

4.  Roles of protein kinase C, Ca2+, Pyk2, and c-Src in agonist activation of rat lacrimal gland p42/p44 MAPK.

Authors:  Robin R Hodges; Jose D Rios; Joanna Vrouvlianis; Isao Ota; Driss Zoukhri; Darlene A Dartt
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-08       Impact factor: 4.799

5.  Carbachol-stimulated transactivation of epidermal growth factor receptor and mitogen-activated protein kinase in T(84) cells is mediated by intracellular Ca2+, PYK-2, and p60(src).

Authors:  S J Keely; S O Calandrella; K E Barrett
Journal:  J Biol Chem       Date:  2000-04-28       Impact factor: 5.157

6.  Signal transduction cascade in staurosporine-induced prostaglandin E(2) production by rat peritoneal macrophages.

Authors:  K Yamaki; T Yonezawa; K Ohuchi
Journal:  J Pharmacol Exp Ther       Date:  2000-04       Impact factor: 4.030

7.  Crystal structures of c-Src reveal features of its autoinhibitory mechanism.

Authors:  W Xu; A Doshi; M Lei; M J Eck; S C Harrison
Journal:  Mol Cell       Date:  1999-05       Impact factor: 17.970

8.  Interactions between two cytoskeleton-associated tyrosine kinases: calcium-dependent tyrosine kinase and focal adhesion tyrosine kinase.

Authors:  X Li; R C Dy; W G Cance; L M Graves; H S Earp
Journal:  J Biol Chem       Date:  1999-03-26       Impact factor: 5.157

9.  Protein-tyrosine kinase Pyk2 is involved in interleukin-2 production by Jurkat T cells via its tyrosine 402.

Authors:  T Katagiri; T Takahashi; T Sasaki; S Nakamura; S Hattori
Journal:  J Biol Chem       Date:  2000-06-30       Impact factor: 5.157

10.  An essential role for ectodomain shedding in mammalian development.

Authors:  J J Peschon; J L Slack; P Reddy; K L Stocking; S W Sunnarborg; D C Lee; W E Russell; B J Castner; R S Johnson; J N Fitzner; R W Boyce; N Nelson; C J Kozlosky; M F Wolfson; C T Rauch; D P Cerretti; R J Paxton; C J March; R A Black
Journal:  Science       Date:  1998-11-13       Impact factor: 47.728

View more
  14 in total

1.  Dependence of corneal epithelial cell proliferation on modulation of interactions between ERK1/2 and NKCC1.

Authors:  Zheng Wang; Victor N Bildin; Hua Yang; José E Capó-Aponte; Yuanquan Yang; Peter S Reinach
Journal:  Cell Physiol Biochem       Date:  2011-12-14

2.  Tear film mucins: front line defenders of the ocular surface; comparison with airway and gastrointestinal tract mucins.

Authors:  Robin R Hodges; Darlene A Dartt
Journal:  Exp Eye Res       Date:  2013-08-14       Impact factor: 3.467

Review 3.  Mechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle Disorders.

Authors:  F V Brozovich; C J Nicholson; C V Degen; Yuan Z Gao; M Aggarwal; K G Morgan
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

4.  Proteinase-activated receptor 2-mediated calcium signaling in hepatocellular carcinoma cells.

Authors:  Roland Kaufmann; Franziska Mussbach; Petra Henklein; Utz Settmacher
Journal:  J Cancer Res Clin Oncol       Date:  2010-12-02       Impact factor: 4.553

5.  Protein Kinase C Signaling in Adenoviral Infection.

Authors:  Mohammad A Yousuf; Ji Sun Lee; Xiaohong Zhou; Mirja Ramke; Jeong Yoon Lee; James Chodosh; Jaya Rajaiya
Journal:  Biochemistry       Date:  2016-10-11       Impact factor: 3.162

6.  Role of PKCα activation of Src, PI-3K/AKT, and ERK in EGF-stimulated proliferation of rat and human conjunctival goblet cells.

Authors:  Dayu Li; Marie A Shatos; Robin R Hodges; Darlene A Dartt
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-21       Impact factor: 4.799

7.  Characterization of P2X7 purinergic receptors and their function in rat lacrimal gland.

Authors:  Robin R Hodges; Joanna Vrouvlianis; Marie A Shatos; Darlene A Dartt
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-07-15       Impact factor: 4.799

8.  Role of cPKCalpha and nPKCepsilon in EGF-stimulated goblet cell proliferation.

Authors:  Marie A Shatos; Robin R Hodges; Yoshia Oshi; Jeffrey A Bair; Driss Zoukhri; Claire Kublin; Kameran Lashkari; Darlene A Dartt
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-09-29       Impact factor: 4.799

9.  A novel Bruton's tyrosine kinase inhibitor CC-292 in combination with the proteasome inhibitor carfilzomib impacts the bone microenvironment in a multiple myeloma model with resultant antimyeloma activity.

Authors:  H Eda; L Santo; D D Cirstea; A J Yee; T A Scullen; N Nemani; Y Mishima; P R Waterman; S Arastu-Kapur; E Evans; J Singh; C J Kirk; W F Westlin; N S Raje
Journal:  Leukemia       Date:  2014-02-12       Impact factor: 11.528

10.  Effect of histamine on Ca(2+)-dependent signaling pathways in rat conjunctival goblet cells.

Authors:  Dayu Li; Richard B Carozza; Marie A Shatos; Robin R Hodges; Darlene A Dartt
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-10-05       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.